[{"id":"e15bb21d-5fb8-4e9d-8347-60a7b3d548d7","acronym":"TheraSphere","url":"https://clinicaltrials.gov/study/NCT00906984","created_at":"2021-01-18T03:30:04.724Z","updated_at":"2024-07-02T16:35:24.192Z","phase":"","brief_title":"TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma","source_id_and_acronym":"NCT00906984 - TheraSphere","lead_sponsor":"University of California, Irvine","biomarkers":" AFP","pipe":"","alterations":" ","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TheraSphere (yttrium 90 microspheres)"],"overall_status":"Approved for marketing","enrollment":"","initiation":"","start_date":"","primary_txt":"","primary_completion_date":"","study_txt":"","study_completion_date":"","last_update_posted":"2024-01-08"},{"id":"8f341beb-ea98-4529-9ae4-ee4c9f81d66b","acronym":"","url":"https://clinicaltrials.gov/study/NCT01176604","created_at":"2021-01-18T04:41:50.199Z","updated_at":"2024-07-02T16:36:02.427Z","phase":"","brief_title":"Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma","source_id_and_acronym":"NCT01176604","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" AFP","pipe":"","alterations":" ","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TheraSphere (yttrium 90 microspheres)"],"overall_status":"Completed","enrollment":" Enrollment 299","initiation":"Initiation: 08/04/2010","start_date":" 08/04/2010","primary_txt":" Primary completion: 04/09/2021","primary_completion_date":" 04/09/2021","study_txt":" Completion: 04/09/2021","study_completion_date":" 04/09/2021","last_update_posted":"2022-10-14"},{"id":"e27f1808-0b58-4858-8e0b-e3c933950bde","acronym":"","url":"https://clinicaltrials.gov/study/NCT02072356","created_at":"2021-01-18T09:32:53.284Z","updated_at":"2024-07-02T16:36:03.182Z","phase":"Phase 1","brief_title":"Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery","source_id_and_acronym":"NCT02072356","lead_sponsor":"Ohio State University Comprehensive Cancer Center","biomarkers":" AFP","pipe":"","alterations":" ","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TheraSphere (yttrium 90 microspheres)"],"overall_status":"Completed","enrollment":" Enrollment 290","initiation":"Initiation: 10/11/2010","start_date":" 10/11/2010","primary_txt":" Primary completion: 06/15/2021","primary_completion_date":" 06/15/2021","study_txt":" Completion: 06/15/2021","study_completion_date":" 06/15/2021","last_update_posted":"2022-09-30"},{"id":"3ebeca03-679d-4288-8eb0-dc61ba1684ba","acronym":"MispheC","url":"https://clinicaltrials.gov/study/NCT01912053","created_at":"2021-01-18T08:37:13.021Z","updated_at":"2024-07-02T16:37:10.820Z","phase":"Phase 2","brief_title":"Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma","source_id_and_acronym":"NCT01912053 - MispheC","lead_sponsor":"Center Eugene Marquis","biomarkers":" CA 19-9","pipe":"","alterations":" ","tags":["CA 19-9"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • gemcitabine • TheraSphere (yttrium 90 microspheres)"],"overall_status":"Completed","enrollment":" Enrollment 41","initiation":"Initiation: 09/01/2013","start_date":" 09/01/2013","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":" Completion: 11/01/2017","study_completion_date":" 11/01/2017","last_update_posted":"2018-05-11"},{"id":"0de4063c-528c-47e5-8a5b-010691473205","acronym":"","url":"https://clinicaltrials.gov/study/NCT00039078","created_at":"2021-01-18T00:02:24.582Z","updated_at":"2024-07-02T16:37:20.678Z","phase":"Phase 2","brief_title":"Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery","source_id_and_acronym":"NCT00039078","lead_sponsor":"Allan Tsung","biomarkers":" AFP","pipe":" | ","alterations":" AFP elevation","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AFP elevation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TheraSphere (yttrium 90 microspheres)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 08/01/2000","start_date":" 08/01/2000","primary_txt":" Primary completion: 08/01/2000","primary_completion_date":" 08/01/2000","study_txt":" Completion: 08/01/2000","study_completion_date":" 08/01/2000","last_update_posted":"2017-06-26"}]